Synairgen (SNG)

 

Latest News

Holding(s) in Company

RNS Number: 3085Z Synairgen plc 13 March 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Synairgen Plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disp...

Additional Positive Data in Lung Fibrosis

RNS Number: 1286Z Synairgen plc 10 March 2017 Press release Synairgen plc ('Synairgen' or the 'Company') Additional Positive Data in Lung Fibrosis - Phase I clinical trial scheduled to start in H2 2017 Southampton, UK - 10 March 2017: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces further positive data from it...

Holding(s) in Company

RNS Number: 3878U Synairgen plc 17 January 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Synairgen plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights x An acquisition or dis...

Holding(s) in Company

RNS Number: 4682M Synairgen plc 13 October 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Synairgen plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights x An acquisition or dis...

All News

DateHeadlineSource
13-03-17Holding(s) in CompanyRNS
10-03-17Additional Positive Data in Lung FibrosisRNS
17-01-17Holding(s) in CompanyRNS
13-10-16Holding(s) in CompanyRNS
12-10-16Synairgen updates on AZD9412StockMarketWire
12-10-16FTSE up on airlines, house builders after sluggish startStockMarketWire
12-10-16AZD9412 Clinical Trial UpdateRNS
22-09-16Broker Forecast - N+1 Singer issues a broker note on Synairgen PLCStockMarketWire
22-09-16Synairgen widens H1 pretax lossStockMarketWire
22-09-16Interim results for six months ended 30 June 2016RNS
08-09-16Notice of Interim ResultsRNS
14-06-16Result of AGMRNS
07-06-16Are Synairgen plc or Immupharma plc better investments than AstraZeneca plc?Motley Fool
17-05-16Posting of Annual Report and Notice of AGMRNS
21-04-16Holding(s) in CompanyRNS
23-03-16Synairgen options exercised StockMarketWire
23-03-16Exercise of OptionsRNS
22-03-16Broker Forecast - finnCap issues a broker note on Synairgen PLCStockMarketWire
22-03-16Preliminary results for the year ended 31 Dec 2015RNS
22-03-16Positive LOXL2 resultsRNS
03-03-16Notice of Preliminary ResultsRNS
16-11-15Adoption of FRS 101 - Reduced Disclosure FrameworkRNS
13-11-15Holding(s) in CompanyRNS
13-11-15Holding(s) in CompanyRNS
13-11-15Holding(s) in CompanyRNS
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Directors' Share PurchaseRNS
28-10-15Grant of optionsRNS
16-09-15Synairgen swings to H1 pretax lossStockMarketWire
16-09-15Interim ResultsRNS
21-08-15Synairgen schedules interimsStockMarketWire
21-08-15Notice of Interim ResultsRNS
05-08-15Synairgen announces research collaborationStockMarketWire
05-08-15Synairgen announces research collaborationStockMarketWire
05-08-15Synairgen announces research collaborationRNS
22-07-15SNG says AstraZeneca beings Phase II Trial of AZD9412StockMarketWire
22-07-15AstraZeneca commences Phase II TrialRNS

RSS feeds

  • Editorial news feed for LSE:SNG Editorial
  • Regulatory news feed for LSE:SNG Regulatory